Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nursing Assessment | 21 | 2012 | 27 | 2.690 |
Why?
|
| Emergency Nursing | 13 | 2010 | 13 | 2.310 |
Why?
|
| Pneumothorax | 4 | 2011 | 15 | 1.270 |
Why?
|
| Critical Care | 5 | 2011 | 50 | 1.160 |
Why?
|
| Infusions, Intraosseous | 4 | 2011 | 4 | 0.910 |
Why?
|
| Emergency Treatment | 5 | 2008 | 26 | 0.850 |
Why?
|
| Emergency Medical Services | 4 | 2011 | 82 | 0.830 |
Why?
|
| Emergencies | 7 | 2011 | 28 | 0.650 |
Why?
|
| Heat Exhaustion | 2 | 2010 | 2 | 0.630 |
Why?
|
| First Aid | 3 | 2006 | 6 | 0.570 |
Why?
|
| Humans | 40 | 2016 | 28121 | 0.540 |
Why?
|
| Sternum | 2 | 2011 | 7 | 0.530 |
Why?
|
| Extremities | 1 | 2016 | 22 | 0.500 |
Why?
|
| Transportation of Patients | 2 | 2005 | 29 | 0.480 |
Why?
|
| Heat Stroke | 2 | 2010 | 2 | 0.470 |
Why?
|
| Ruthenium | 7 | 2012 | 10 | 0.470 |
Why?
|
| Hemorrhage | 1 | 2016 | 265 | 0.440 |
Why?
|
| Frostbite | 2 | 2008 | 2 | 0.440 |
Why?
|
| Organometallic Compounds | 6 | 2013 | 41 | 0.410 |
Why?
|
| Wounds and Injuries | 2 | 2008 | 185 | 0.400 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2012 | 1 | 0.390 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2012 | 1 | 0.390 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2012 | 3 | 0.390 |
Why?
|
| Hyponatremia | 1 | 2012 | 17 | 0.380 |
Why?
|
| Phosphines | 6 | 2013 | 7 | 0.370 |
Why?
|
| Brain Injuries | 1 | 2012 | 49 | 0.370 |
Why?
|
| Nickel | 4 | 2012 | 15 | 0.370 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 25 | 0.360 |
Why?
|
| Iatrogenic Disease | 1 | 2011 | 14 | 0.360 |
Why?
|
| Thigh | 1 | 2011 | 39 | 0.360 |
Why?
|
| Humerus | 1 | 2011 | 10 | 0.360 |
Why?
|
| Coordination Complexes | 4 | 2012 | 27 | 0.360 |
Why?
|
| Multiple Trauma | 1 | 2011 | 23 | 0.360 |
Why?
|
| Bicycling | 1 | 2011 | 41 | 0.360 |
Why?
|
| Tibia | 1 | 2011 | 39 | 0.360 |
Why?
|
| Alkenes | 5 | 2012 | 15 | 0.350 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 6 | 0.330 |
Why?
|
| Neisseria gonorrhoeae | 3 | 2017 | 6 | 0.330 |
Why?
|
| Male | 16 | 2011 | 13487 | 0.330 |
Why?
|
| Iron | 4 | 2017 | 116 | 0.300 |
Why?
|
| Accidental Falls | 1 | 2008 | 32 | 0.300 |
Why?
|
| Hypertension | 1 | 2011 | 309 | 0.300 |
Why?
|
| Crohn Disease | 1 | 2008 | 32 | 0.300 |
Why?
|
| Colitis, Ulcerative | 1 | 2008 | 31 | 0.300 |
Why?
|
| Resuscitation | 2 | 2011 | 59 | 0.300 |
Why?
|
| Fever | 1 | 2008 | 31 | 0.290 |
Why?
|
| Foot Injuries | 1 | 2006 | 5 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 296 | 0.270 |
Why?
|
| Amputation, Traumatic | 1 | 2006 | 5 | 0.270 |
Why?
|
| Catheterization, Central Venous | 1 | 2006 | 38 | 0.260 |
Why?
|
| Adult | 11 | 2011 | 7757 | 0.250 |
Why?
|
| Facial Bones | 1 | 2006 | 7 | 0.250 |
Why?
|
| Skull Fractures | 1 | 2006 | 19 | 0.250 |
Why?
|
| Perioperative Nursing | 1 | 2005 | 2 | 0.250 |
Why?
|
| Conscious Sedation | 1 | 2005 | 10 | 0.240 |
Why?
|
| RNA, Bacterial | 2 | 2017 | 65 | 0.240 |
Why?
|
| Leg | 2 | 2004 | 134 | 0.240 |
Why?
|
| Knowledge | 1 | 2005 | 15 | 0.240 |
Why?
|
| Air Ambulances | 1 | 2005 | 20 | 0.240 |
Why?
|
| Health Surveys | 1 | 2005 | 82 | 0.240 |
Why?
|
| Hypertension, Malignant | 1 | 2004 | 3 | 0.230 |
Why?
|
| Rural Population | 1 | 2005 | 107 | 0.220 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 126 | 0.220 |
Why?
|
| Physical Examination | 3 | 2011 | 51 | 0.220 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2003 | 1 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 44 | 0.210 |
Why?
|
| Lightning Injuries | 1 | 2003 | 1 | 0.210 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 64 | 0.210 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 98 | 0.190 |
Why?
|
| Terphenyl Compounds | 2 | 2013 | 2 | 0.190 |
Why?
|
| Stroke | 1 | 2005 | 252 | 0.190 |
Why?
|
| Electric Countershock | 1 | 2001 | 29 | 0.180 |
Why?
|
| Intubation, Intratracheal | 1 | 2001 | 27 | 0.180 |
Why?
|
| Hydrogen | 2 | 2012 | 56 | 0.180 |
Why?
|
| Benzene Derivatives | 2 | 2011 | 7 | 0.180 |
Why?
|
| Amines | 2 | 2012 | 13 | 0.180 |
Why?
|
| Attitude to Death | 1 | 2000 | 13 | 0.170 |
Why?
|
| Equipment Design | 3 | 2011 | 217 | 0.170 |
Why?
|
| Acute Disease | 3 | 2005 | 158 | 0.170 |
Why?
|
| Pyridines | 2 | 2011 | 108 | 0.170 |
Why?
|
| Nursing Staff, Hospital | 1 | 2000 | 19 | 0.160 |
Why?
|
| Catheters, Indwelling | 1 | 1999 | 19 | 0.160 |
Why?
|
| Crystallography, X-Ray | 9 | 2013 | 223 | 0.160 |
Why?
|
| Drug Eruptions | 1 | 1999 | 7 | 0.160 |
Why?
|
| Risk Factors | 4 | 2008 | 2084 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2000 | 24 | 0.160 |
Why?
|
| Scyphozoa | 1 | 1999 | 1 | 0.160 |
Why?
|
| Bites and Stings | 1 | 1999 | 6 | 0.160 |
Why?
|
| Compartment Syndromes | 1 | 1999 | 7 | 0.160 |
Why?
|
| Terminal Care | 1 | 2000 | 43 | 0.160 |
Why?
|
| Vancomycin | 1 | 1999 | 58 | 0.160 |
Why?
|
| Body Temperature | 2 | 2010 | 30 | 0.160 |
Why?
|
| Diaphragm | 1 | 1999 | 14 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 372 | 0.150 |
Why?
|
| Accidents, Traffic | 1 | 1999 | 28 | 0.150 |
Why?
|
| Pleural Effusion | 1 | 1998 | 14 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 143 | 0.150 |
Why?
|
| Models, Molecular | 8 | 2013 | 453 | 0.150 |
Why?
|
| Heparin | 2 | 2003 | 110 | 0.150 |
Why?
|
| Nursing Staff | 1 | 1997 | 7 | 0.140 |
Why?
|
| Masks | 1 | 1997 | 10 | 0.140 |
Why?
|
| Infection Control | 1 | 1997 | 33 | 0.130 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1997 | 28 | 0.130 |
Why?
|
| Heterocyclic Compounds | 2 | 2009 | 15 | 0.130 |
Why?
|
| Rubredoxins | 2 | 1992 | 2 | 0.130 |
Why?
|
| Bandages | 1 | 2016 | 14 | 0.130 |
Why?
|
| Tourniquets | 1 | 2016 | 15 | 0.130 |
Why?
|
| Archaea | 2 | 1992 | 54 | 0.120 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2013 | 156 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 523 | 0.120 |
Why?
|
| Ethylenes | 2 | 2012 | 5 | 0.110 |
Why?
|
| Time Factors | 2 | 2011 | 1593 | 0.110 |
Why?
|
| Child | 4 | 2005 | 2242 | 0.110 |
Why?
|
| Magnetics | 2 | 2011 | 14 | 0.110 |
Why?
|
| RNA, Small Untranslated | 1 | 2013 | 2 | 0.110 |
Why?
|
| Palladium | 1 | 2013 | 9 | 0.110 |
Why?
|
| RNA Stability | 1 | 2013 | 29 | 0.110 |
Why?
|
| Oxygen | 2 | 2012 | 233 | 0.110 |
Why?
|
| Protein Conformation | 2 | 1999 | 257 | 0.100 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 1993 | 6 | 0.100 |
Why?
|
| Aged | 3 | 2011 | 5416 | 0.100 |
Why?
|
| Carbon | 2 | 2012 | 108 | 0.100 |
Why?
|
| Nitroglycerin | 1 | 1992 | 27 | 0.100 |
Why?
|
| Catalysis | 5 | 2012 | 133 | 0.100 |
Why?
|
| Molecular Structure | 6 | 2013 | 243 | 0.100 |
Why?
|
| Lewis Bases | 1 | 2012 | 1 | 0.100 |
Why?
|
| Syndrome | 1 | 2012 | 78 | 0.100 |
Why?
|
| Ligands | 5 | 2011 | 176 | 0.100 |
Why?
|
| Hospital Rapid Response Team | 1 | 2011 | 1 | 0.090 |
Why?
|
| Photosystem II Protein Complex | 1 | 2011 | 3 | 0.090 |
Why?
|
| Manganese | 1 | 2011 | 24 | 0.090 |
Why?
|
| Bridged-Ring Compounds | 1 | 2011 | 18 | 0.090 |
Why?
|
| Drug Administration Routes | 1 | 2011 | 8 | 0.090 |
Why?
|
| Transition Elements | 1 | 2011 | 2 | 0.090 |
Why?
|
| Trees | 1 | 2011 | 46 | 0.090 |
Why?
|
| Oxidation-Reduction | 5 | 2011 | 362 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 485 | 0.090 |
Why?
|
| Copper | 1 | 2011 | 47 | 0.090 |
Why?
|
| Calcium | 1 | 2011 | 235 | 0.080 |
Why?
|
| Trauma Centers | 1 | 2011 | 119 | 0.080 |
Why?
|
| Molecular Conformation | 4 | 2011 | 67 | 0.080 |
Why?
|
| Regulon | 1 | 2010 | 18 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2010 | 118 | 0.080 |
Why?
|
| Benzylidene Compounds | 1 | 2009 | 29 | 0.080 |
Why?
|
| Cryotherapy | 1 | 2008 | 10 | 0.070 |
Why?
|
| Polymers | 1 | 2009 | 117 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2008 | 29 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2008 | 18 | 0.070 |
Why?
|
| Body Temperature Regulation | 1 | 2008 | 12 | 0.070 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 8 | 0.070 |
Why?
|
| Immobilization | 1 | 2008 | 15 | 0.070 |
Why?
|
| Swimming | 1 | 2008 | 32 | 0.070 |
Why?
|
| X-Ray Diffraction | 4 | 2009 | 41 | 0.070 |
Why?
|
| Quantum Theory | 3 | 2013 | 22 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 91 | 0.070 |
Why?
|
| Methane | 2 | 2009 | 51 | 0.070 |
Why?
|
| Thoracostomy | 1 | 2006 | 4 | 0.070 |
Why?
|
| Female | 4 | 2008 | 15156 | 0.070 |
Why?
|
| Replantation | 1 | 2006 | 7 | 0.070 |
Why?
|
| Chest Tubes | 1 | 2006 | 9 | 0.070 |
Why?
|
| Imidazoles | 2 | 2003 | 63 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2006 | 42 | 0.060 |
Why?
|
| Maxillary Fractures | 1 | 2006 | 1 | 0.060 |
Why?
|
| Zygomatic Fractures | 1 | 2006 | 2 | 0.060 |
Why?
|
| Nasal Bone | 1 | 2006 | 5 | 0.060 |
Why?
|
| Causality | 1 | 2006 | 14 | 0.060 |
Why?
|
| Tooth Fractures | 1 | 2006 | 3 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 92 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2006 | 62 | 0.060 |
Why?
|
| Orbital Fractures | 1 | 2006 | 6 | 0.060 |
Why?
|
| Baseball | 1 | 2006 | 10 | 0.060 |
Why?
|
| Cytokines | 1 | 2008 | 445 | 0.060 |
Why?
|
| Safety Management | 1 | 2005 | 14 | 0.060 |
Why?
|
| Montana | 1 | 2005 | 5 | 0.060 |
Why?
|
| Northwestern United States | 1 | 2005 | 9 | 0.060 |
Why?
|
| Epidemiologic Research Design | 1 | 2005 | 10 | 0.060 |
Why?
|
| Organizational Objectives | 1 | 2005 | 16 | 0.060 |
Why?
|
| Population Density | 1 | 2005 | 21 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2005 | 36 | 0.060 |
Why?
|
| Certification | 1 | 2005 | 15 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 37 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2005 | 48 | 0.060 |
Why?
|
| Accreditation | 1 | 2005 | 36 | 0.060 |
Why?
|
| Biomechanical Phenomena | 1 | 2006 | 180 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2005 | 55 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2005 | 66 | 0.060 |
Why?
|
| Critical Illness | 1 | 2005 | 68 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2011 | 2380 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 56 | 0.050 |
Why?
|
| Middle Aged | 2 | 2006 | 7164 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2011 | 180 | 0.050 |
Why?
|
| Fluid Therapy | 1 | 2003 | 14 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2003 | 76 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 733 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 2021 | 0.050 |
Why?
|
| Warfarin | 1 | 2003 | 94 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 1992 | 131 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2005 | 873 | 0.050 |
Why?
|
| Laryngeal Masks | 1 | 2001 | 6 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 294 | 0.040 |
Why?
|
| Pediatric Nursing | 1 | 2000 | 3 | 0.040 |
Why?
|
| Professional-Family Relations | 1 | 2000 | 22 | 0.040 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1999 | 3 | 0.040 |
Why?
|
| Family | 1 | 2000 | 98 | 0.040 |
Why?
|
| Azurin | 1 | 1999 | 2 | 0.040 |
Why?
|
| Rupture | 1 | 1999 | 12 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2000 | 123 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 148 | 0.040 |
Why?
|
| Young Adult | 1 | 2006 | 2731 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1999 | 71 | 0.040 |
Why?
|
| Life Support Care | 1 | 1997 | 2 | 0.040 |
Why?
|
| Riboswitch | 1 | 2017 | 1 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2017 | 45 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 58 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2011 | 35 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 214 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1992 | 689 | 0.030 |
Why?
|
| Adsorption | 1 | 2013 | 32 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 2013 | 7 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 24 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 64 | 0.030 |
Why?
|
| Surface Properties | 1 | 2013 | 134 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 118 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 1993 | 37 | 0.030 |
Why?
|
| Drug Stability | 1 | 1992 | 23 | 0.030 |
Why?
|
| Mathematics | 1 | 1992 | 42 | 0.030 |
Why?
|
| Analgesics | 1 | 1993 | 38 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 1992 | 39 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 1993 | 29 | 0.030 |
Why?
|
| Crystallization | 1 | 1992 | 50 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 132 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1992 | 93 | 0.020 |
Why?
|
| Ethers | 1 | 2012 | 5 | 0.020 |
Why?
|
| Zinc | 1 | 1992 | 59 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1992 | 78 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2012 | 22 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1992 | 87 | 0.020 |
Why?
|
| Polymerization | 1 | 2012 | 14 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 402 | 0.020 |
Why?
|
| Oxides | 1 | 2011 | 14 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 451 | 0.020 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 22 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1992 | 605 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 1050 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1993 | 219 | 0.020 |
Why?
|
| Methylene Chloride | 1 | 2010 | 1 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2010 | 47 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 50 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 76 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 192 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 326 | 0.020 |
Why?
|
| Computational Biology | 1 | 2010 | 155 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2007 | 17 | 0.020 |
Why?
|
| Animals | 1 | 1999 | 10399 | 0.010 |
Why?
|
| Triazoles | 1 | 2003 | 16 | 0.010 |
Why?
|
| Hydrocarbons | 1 | 2003 | 41 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 545 | 0.010 |
Why?
|